Vasin Lee / Shutterstock.com
Proactively managing patent portfolios is an investment that pays for itself in reduced patent costs. Bruno Reynolds, who works at the consultancy arm of Isis Innovation, the technology transfer company of the University of Oxford, explains more.
According to patent information company IFI Claims, 66% of what it said were the most prolific patenting companies also feature in the Financial Times’s top 500—compelling evidence that research and development (R&D) today creates tomorrow’s successes.
But which R&D outputs will be valuable? Which patents should companies and universities invest in?
Initial patent filings are cheap, making it easy to justify a cover-all-bases approach of patenting a high proportion of R&D outputs.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Bruno Reynolds; Oxford Gene Technology; Isis Enterprise; R&D; IP portfolio; University of Oxford
